The therapeutic application of heat is very effective in cancer treatment. Both hyperthermia,
ie, heating to 39–45° C to induce sensitization to radiotherapy and chemotherapy, and …

The conventional cancer treatment modalities such as radiotherapy and chemotherapy
suffer from several limitations; hence, their efficiency needs to be improved with other …

Mild hyperthermia, local heating of the tumour up to temperatures< 43° C, has been
clinically applied for almost four decades and has been proven to substantially enhance the …

Heating as a medical intervention in cancer treatment is an ancient approach, but effective
deep heating techniques are lacking in modern practice. The use of electromagnetic …

Moderate hyperthermia at temperatures between 40 and 44° C is a multifaceted therapeutic
modality. It is a potent radiosensitizer, interacts favorably with a host of chemotherapeutic …

Background The global burden of cervical cancer remains high with the highest morbidity
and mortality rates reported in developing countries. Hyperthermia as a chemo-and …

Immunotherapy has demonstrated great clinical success in certain cancers, driven primarily
by immune checkpoint blockade and adoptive cell therapies. Immunotherapy can elicit …

Globally, cervical cancer has the fourth highest cancer incidence and mortality in women.
Cervical cancer is unique because it has effective prevention, screening, and treatment …

Simple Summary Hyperthermia (HT) is a promising therapeutic option for multiple cancer
entities as it has the potential to increase the cytotoxicity of radiotherapy (RT) and …

Hyperthermia, ie heating the tumor to a temperature of 40–43° C is considered by many a
valuable treatment to sensitize tumor cells to radiotherapy and chemotherapy. In recent …